REQUEST A DEMO
Total
USD $0.00
Search more companies

Vaduse Dermatologie Sp. z o.o. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing
Secondary Activities: Merchant Wholesalers, Durable Goods | Retail Trade | Scientific Research and Development Services
Full name: Vaduse Dermatologie Sp. z o.o. Profile Updated: May 27, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Vaduse Dermatologie Sp. z o.o. is an enterprise based in Poland. Its main office is in Lublin. The company operates in the Pharmaceutical Preparation Manufacturing sector. The company was established on November 20, 2020. In 2023, the company reported a net sales revenue increase of 335.61%. Its total assets grew by 34.78% over the same period.

Headquarters
Ul. Tomasza Zana 43/2.1
Lublin; Lubelskie; Postal Code: 20-601

Contact Details: Purchase the Vaduse Dermatologie Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Vaduse Dermatologie Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Vaduse Dermatologie Sp. z o.o. report to view the information.
Incorporation Date:
November 20, 2020
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
34%
Purchase this report to view the information.
33%
Purchase this report to view the information.
33%
Company Performance
Financial values in the chart are available after Vaduse Dermatologie Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
335.61%
Total operating revenue
327.64%
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
N/A
Total assets
34.78%
Total equity
29.39%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?